Allworth Financial LP Novo Cure LTD Transaction History
Allworth Financial LP
- $17.4 Billion
- Q1 2025
A detailed history of Allworth Financial LP transactions in Novo Cure LTD stock. As of the latest transaction made, Allworth Financial LP holds 336 shares of NVCR stock, worth $5,967. This represents 0.0% of its overall portfolio holdings.
Number of Shares
336
Previous 428
21.5%
Holding current value
$5,967
Previous $12,000
58.33%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding NVCR
# of Institutions
292Shares Held
74.7MCall Options Held
1.77MPut Options Held
538K-
Black Rock Inc. New York, NY12.1MShares$215 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.3MShares$200 Million0.0% of portfolio
-
Capital International Investors Los Angeles, CA8.87MShares$158 Million0.05% of portfolio
-
Capital World Investors Los Angeles, CA4.82MShares$85.5 Million0.02% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT2.74MShares$48.7 Million5.68% of portfolio
About NovoCure Ltd
- Ticker NVCR
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 104,950,000
- Market Cap $1.86B
- Description
- NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...